Aurinia Pharmaceuticals Inc (AUPH) Financials

AUPH Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 516.6 million 157.2 million
2023-12-31 548.1 million 170.1 million
2023-09-30 555.0 million 163.1 million
2023-06-30 548.9 million 156.6 million

AUPH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -18.6 million ?
2023-12-31 14.8 million 11.8 million
2023-09-30 -13.2 million 11.8 million
2023-06-30 -3.1 million 12.3 million

AUPH Net Income

No data available :(

AUPH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 319.9 million - -
2023-12-31 350.5 million - 97.6 million
2023-09-30 337.9 million - 93.2 million
2023-06-30 350.7 million - 101.2 million

AUPH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 144.0 million
2023-12-31 143.8 million
2023-09-30 142.8 million
2023-06-30 142.8 million

AUPH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 11999 5.6 million - -
2023-12-31 49731 10.2 million 50.1 million -
2023-09-30 105000 13.6 million 47.8 million -
2023-06-30 227000 12.7 million 47.1 million -

AUPH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 50.3 million 7.8 million
2023-12-31 45.1 million 5.4 million
2023-09-30 54.5 million 6.8 million
2023-06-30 41.5 million 1.6 million

AUPH

Price: $5.10

52 week price:
4.71
12.43

Earnings Per Share: -0.54 USD

P/E Ratio: -15.29

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 2.2 million

Ebitda: -13.4 million

Market Capitalization: 729.4 million

Links: